Wei Yan
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biochemistry top 1%
- Lipid metabolism and biosynthesis
Papers in
- Oncology 26
- Pancreatic and Hepatic Oncology Research 10
-
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 5
- Co-authors
- Christopher M. Jenkins (4 shared papers)David J. Mancuso (4 shared papers)Richard W. Gross (4 shared papers)Harold F. Sims (3 shared papers)Beverly Gibson (1 shared paper)Marina Pasca di Magliano (9 shared papers)Yaqing Zhang (8 shared papers)Meredith A. Collins (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)Cancer Cell (4 papers)Journal of Biological Chemistry (4 papers)Oncotarget (3 papers)Organic Chemistry Frontiers (3 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Wei Yan
90 papers receiving 4.9k citations
Wei Yan's Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 1.1k
- Biochemistry 484
- Oncology 1.2k
- Molecular Biology 2.4k
- Immunology 563
Countries citing papers authored by Wei Yan
This map shows the geographic impact of Wei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yan more than expected).
Fields of papers citing papers by Wei Yan
This network shows the impact of papers produced by Wei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yan. The network helps show where Wei Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification, Cloning, Expression, and Purification of Three Novel Human Calcium-independent Phospholipase A2 Family Members Possessing Triacylglycerol Lipase and Acylglycerol Transacylase Activities Hit paper breakdown → | 2004 | 705 |
| 2 | The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex Hit paper breakdown → | 2013 | 583 |
| 3 | 2011 | 361 | |
| 4 | 2020 | 293 | |
| 5 | 2012 | 263 | |
| 6 | 2013 | 229 | |
| 7 | 2013 | 167 | |
| 8 | 2019 | 149 | |
| 9 | 2023 | 121 | |
| 10 | 2013 | 108 | |
| 11 | 2021 | 101 | |
| 12 | 2005 | 87 | |
| 13 | 2017 | 83 | |
| 14 | 2023 | 78 | |
| 15 | 2014 | 76 | |
| 16 | 2011 | 72 | |
| 17 | 2018 | 72 | |
| 18 | 2022 | 71 | |
| 19 | 2021 | 62 | |
| 20 | 2022 | 54 |
About Wei Yan
Wei Yan is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Hematology and Immunology, having authored 96 papers that have together received 5.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Synthesis and biological activity (8 papers), Protein Degradation and Inhibitors (7 papers), Synthesis of Organic Compounds (6 papers), Catalytic C–H Functionalization Methods (6 papers), Prostate Cancer Treatment and Research (5 papers), Fungal Plant Pathogen Control (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Biochemistry (484 citations), Oncology (1.2k citations), Molecular Biology (2.4k citations) and Immunology (563 citations). Wei Yan has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Christopher M. Jenkins, David J. Mancuso, Richard W. Gross, Harold F. Sims, Beverly Gibson, Marina Pasca di Magliano, Yaqing Zhang, Meredith A. Collins, Hong-yu Li and Filip Bednar. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Cell, Journal of Biological Chemistry, Oncotarget and Organic Chemistry Frontiers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.